These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 3520078)
21. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity. Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771 [TBL] [Abstract][Full Text] [Related]
22. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity. Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726 [TBL] [Abstract][Full Text] [Related]
23. Surface expression of tumor-associated antigens in primary cultured human colonic epithelial cells from carcinomas, benign tumors, and normal tissues. Friedman E; Thor A; Hand PH; Schlom J Cancer Res; 1985 Nov; 45(11 Pt 2):5648-55. PubMed ID: 2413994 [TBL] [Abstract][Full Text] [Related]
24. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535 [TBL] [Abstract][Full Text] [Related]
25. Immunoperoxidase localization of a high-molecular-weight mucin recognized by monoclonal antibody 1D3. Gangopadhyay A; Bhattacharya M; Chatterjee SK; Barlow JJ; Tsukada Y Cancer Res; 1985 Apr; 45(4):1744-52. PubMed ID: 3884144 [TBL] [Abstract][Full Text] [Related]
26. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients. Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823 [TBL] [Abstract][Full Text] [Related]
27. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3. Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317 [TBL] [Abstract][Full Text] [Related]
28. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells. Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184 [TBL] [Abstract][Full Text] [Related]
29. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas. Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421 [TBL] [Abstract][Full Text] [Related]
30. In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexes. Starling JJ; Maciak RS; Law KL; Hinson NA; Briggs SL; Laguzza BC; Johnson DA Cancer Res; 1991 Jun; 51(11):2965-72. PubMed ID: 2032233 [TBL] [Abstract][Full Text] [Related]
32. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells. Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104 [TBL] [Abstract][Full Text] [Related]
33. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary]. Liu MP; Lu ZT; Chen W Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120 [TBL] [Abstract][Full Text] [Related]
34. Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models. Lee CH; Xue H; Sutcliffe M; Gout PW; Huntsman DG; Miller DM; Gilks CB; Wang YZ Gynecol Oncol; 2005 Jan; 96(1):48-55. PubMed ID: 15589579 [TBL] [Abstract][Full Text] [Related]
35. Identification of a human cancer-associated antigen defined with monoclonal antibody. Bhattacharya M; Chatterjee SK; Barlow JJ Cancer Res; 1984 Oct; 44(10):4528-34. PubMed ID: 6380708 [TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody against human gallbladder carcinoma-associated antigen. Koyama S; Mukai R; Fukao K; Arimura H; Iwasaki Y; Osuga T Cancer Res; 1987 Sep; 47(17):4667-73. PubMed ID: 3304618 [TBL] [Abstract][Full Text] [Related]
37. CAR-3, a monoclonal antibody-defined antigen expressed on human carcinomas. Prat M; Morra I; Bussolati G; Comoglio PM Cancer Res; 1985 Nov; 45(11 Pt 2):5799-807. PubMed ID: 2413998 [TBL] [Abstract][Full Text] [Related]
38. Tissue distribution, immunochemical characterization, and biosynthesis of 47D10, a tumor-associated surface glycoprotein. Ho MK; Kato KP; Durda PJ; Murray JH; Wolfe H; Rabin H; Carney WP Cancer Res; 1987 Jan; 47(1):241-50. PubMed ID: 3539319 [TBL] [Abstract][Full Text] [Related]
39. Blood group substance, CEA, and lectins in ovarian tumors. Dietel M; Arps H; Hölzel F; Viale G; Dell'Orto P; Kröger A; Niendorf A Cancer Detect Prev; 1986; 9(5-6):511-20. PubMed ID: 3465441 [TBL] [Abstract][Full Text] [Related]
40. Distribution of two tumor-associated antigens in gastric lesions as detected by two monoclonal antibodies on tissue sections. Stramignoni D; Coda R Cancer Detect Prev; 1985; 8(1-2):193-206. PubMed ID: 4064040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]